Company announcements, research milestones, and field progress.
NEWS
Follow updates from Upstream Biotechnology as we advance SwitchBlade-enabled crop-resilience traits through validation, partnership, and commercial development.
MEDIA CENTER
Press, partner, and company updates in one place.
Recent company progress.
LATEST UPDATES
JULY 30, 2026
Upstream Biotechnology raises seed funding for ‘on-demand’ crop defense tech
Plants already have the tools to respond to a range of biotic and abiotic threats. The problem, says North Carolina-based startup Upstream Biotechnology, is that genes conferring disease resistance can also impose a yield penalty.
COMPANY ANNOUNCEMENT
JULY 28, 2026
Upstream Biotechnology Closes Seed Financing Led by LeVert Ventures to Advance SwitchBlade Crop Resilience Platform
Upstream Biotechnology, Inc., a North Carolina plant biotechnology company developing stress-inducible gene-regulation technologies for crop protection and resilience, today announced the closing of its seed financing.
JANUARY 2025
Upstream Advances Tomato Disease-Resilience Program
Upstream Biotechnology is advancing tomato-focused disease-resilience work designed to combine premium quality traits with broad-spectrum disease-resistance potential.
NOVEMBER 2023
Upstream selected for AgLaunch365 2024 cohort
Selection for AgLaunch365 strengthened Upstream's connection to farmer-focused validation, market insight, and agricultural commercialization support.
JUNE 2024
Upstream initiates small-plot field trials for soybean disease-resistance trait
Field validation began for Upstream's soybean disease-resistance trait, marking a key step in advancing SwitchBlade crop-resilience programs toward partner-ready data packages.
RESEARCH INSIGHT
How plants reprogram cells to fight invaders
Plant immune responses involve sophisticated changes in gene expression, cellular defense, and resource allocation. Upstream's platform is built to translate those insights into practical crop resilience.
THE SCIENCE THAT GOT US HERE
Peer-reviewed research behind the platform.
Upstream's technology builds on decades of research in plant immunity, translational regulation, and the biological balance between defense and growth.
2025
Translational Regulation of Plant Stress Responses: Mechanisms, Pathways, and Applications in Bioengineering
Xiang & Dong, Annual Review of Phytopathology, 2025
2024
H₂O₂ sulfenylates CHE, linking local infection to the establishment of systemic acquired resistance
Cao et al., Science, 2024
MEDIA & PART5NERSHIP INQUIRIES
For press, investors, and strategic partners.
Contact Upstream for company background, technology overview, partnership discussions, and media inquiries.